InNexus Enters R&D Agreement Targeting Cancer with BioInvent of
Sweden, Appoints New Chairman of the Board of Directors
Sep 27 2006
InNexus Biotechnology, Inc. an innovative antibody-driven drug
development company, today announced that it has entered into an R&D
agreement with BioInvent Intern
Medipacs Develops New Photo Activated Polymer Actuator
Medipacs, a Tucson AZ. biotech company, has announced the
development of a new photo (light) activated polymer actuator that
can reversibly expand and contract up to 100% in volume.
Tucson, AZ - Medipacs, a Tucson AZ. biotech company, has
Zila Completes Strategic Divestiture of Nutraceuticals Division
Company Focuses on Cancer Detection Technologies
PHOENIX, AZ - Oct 03, 2006 -- Zila, Inc. (Nasdaq GM: ZILA) has
completed the divestiture of its wholly-owned subsidiary Zila
Nutraceuticals, Inc. for a total cash transaction of $3
